3PBIOVIAN receives the Talent Acceleration Award at the 2024 BWB Awards in Boston
News and updates
Corporate News & Press Releases
3PBIOVIAN strengthens its executive team with the appointment of three new directors
Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO
3P Biopharmaceuticals: building a legacy of innovation and excellence in biotechnology
Biovian announces the successful refinancing of its existing debt package and the securing of new funding to support GeneCity facility expansion
Biovian Unveils the Stonemasonry Work of GeneCity Facility
Biovian announces over €50 million investment in manufacturing facility in Turku, Finland
3P Biopharmaceuticals lands in the United States.
The Regional Minister for Economic and Business Development Mikel Irujo meets with the management of 3P Biopharmaceuticals and its majority shareholder Keensight Capital.
3P Biopharmaceuticals is moving forward with its expansion plan and the adaptation of its facilities.
3P Biopharmaceuticals increases its microbial production capacity with the installation of a 500 L fermenter.
3P Biopharmaceuticals among the 500 fastest growing companies in Spain
3P Biopharmaceuticals brings together leading international experts in biomedicine to celebrate its 15th anniversary.
3P Biopharmaceuticals among the 100 best companies to work for in Spain
Biovian Announces the Appointment of a New Board Member − Dr. Uwe Gottschalk
3P Biopharmaceuticals celebrates its 15th anniversary with Juan Carlos Unzué.